These data supported previous studies done by Brocke-Heidrich et al. and Tsuyama et al., who showed that BCL3 is upregulated by IL-6 at mRNA level as well as at protein level in myeloma cell lines (4–6). The gene discussed is BCL3; the disease is plasma cell myeloma.